Healthcare provider profile · identity verified

Billy R Boring, MD

Family Practice · MCKINNEY, TX · NPI 1073571303

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	293	80
Atorvastatin Calcium	Atorvastatin Calcium	249	73
Amlodipine Besylate	Amlodipine Besylate	231	67
Methylprednisolone	Methylprednisolone	203	140
Metoprolol Succinate	Metoprolol Succinate	201	56
Rosuvastatin Calcium	Rosuvastatin Calcium	192	55
Losartan Potassium	Losartan Potassium	187	56
Metformin Hcl Er	Metformin Hcl	168	52
Metformin Hcl	Metformin Hcl	150	44
Fluticasone Propionate	Fluticasone Propionate	127	60
Pantoprazole Sodium	Pantoprazole Sodium	123	37
Omeprazole	Omeprazole	110	38
Ozempic	Semaglutide	106	21
Tamsulosin Hcl	Tamsulosin Hcl	106	34
Azithromycin	Azithromycin	105	90
Simvastatin	Simvastatin	105	30
Azelastine Hcl	Azelastine Hcl	87	44
Mupirocin	Mupirocin	82	62
Pravastatin Sodium	Pravastatin Sodium	80	21
Ezetimibe	Ezetimibe	78	29
Metoprolol Tartrate	Metoprolol Tartrate	73	19
Gabapentin	Gabapentin	71	24
Montelukast Sodium	Montelukast Sodium	70	19
Alprazolam	Alprazolam	69	suppressed
Trazodone Hcl	Trazodone Hcl	69	15
Potassium Chloride	Potassium Chloride	64	17
Hydrochlorothiazide	Hydrochlorothiazide	61	20
Glipizide Er	Glipizide	58	18
Furosemide	Furosemide	57	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	18
Allopurinol	Allopurinol	55	14
Glimepiride	Glimepiride	55	15
Escitalopram Oxalate	Escitalopram Oxalate	53	17
Lisinopril	Lisinopril	53	15
Lorazepam	Lorazepam	50	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	49	suppressed
Sertraline Hcl	Sertraline Hcl	48	17
Metronidazole	Metronidazole	43	36
Ciprofloxacin Hcl	Ciprofloxacin Hcl	41	32
Spironolactone	Spironolactone	39	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Carvedilol	Carvedilol	38	13
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Mirtazapine	Mirtazapine	37	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Eliquis	Apixaban	33	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Finasteride	Finasteride	30	suppressed
Levofloxacin	Levofloxacin	27	20
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Prednisone	Prednisone	25	22
Amoxicillin	Amoxicillin	24	20
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	22	17
Cholestyramine	Cholestyramine (With Sugar)	22	suppressed
Clindamycin Hcl	Clindamycin Hcl	22	16
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Nystatin	Nystatin	22	14
Cephalexin	Cephalexin	21	19
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Estradiol	Estradiol	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Clonidine	Clonidine	11	suppressed
Erythromycin	Erythromycin Base	11	11
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error